Published in J Lab Clin Med on December 01, 1973
The perturbation of thrombin binding to human platelets by anions. J Clin Invest (1975) 1.07
Adhesion of human platelets to immobilized trimeric collagen. J Cell Biol (1982) 1.00
Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro. Can J Comp Med (1983) 0.93
Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: structure-activity relationships. Agents Actions (1982) 0.87
Evidence for carbohydrate-deficient forms of the major sialoglycoproteins of human platelets, granulocytes and T lymphocytes in individuals with Tn syndrome. Immunology (1983) 0.84
In vivo platelet aggregation in the rat: dependence on extracellular divalent cation and inhibition by nonsteroidal anti-inflammatory drugs. Br J Pharmacol (1984) 0.84
Reversal of shortened platelet survival in rats by the antifibrinolytic agent, epsilon aminocaproic acid. J Clin Invest (1983) 0.78
Dipyridamole: pharmacokinetics and effects on aspects of platelet function in man. Br J Clin Pharmacol (1987) 0.77
Dose-dependent inhibition of experimental arterial thrombosis by carbenicillin and ticarcillin. Am J Pathol (1978) 0.77
Effect of dazoxiben on platelet-vessel wall interaction. Br J Clin Pharmacol (1983) 0.75
Factors influencing platelet function: adhesion, release, and aggregation. Pharmacol Rev (1970) 4.48
Preparation of suspensions of washed platelets from humans. Br J Haematol (1972) 4.02
Platelet aggregation and release of ADP, serotonin and histamine associated with phagocytosis of antigen-antibody complexes. Proc Soc Exp Biol Med (1965) 2.91
Phyllosilicates on Mars and implications for early martian climate. Nature (2005) 2.66
The effect of acetylsalicyclic acid on platelet function. J Exp Med (1968) 2.35
Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest (1999) 2.34
Platelet phagocytosis and aggregation. J Cell Biol (1965) 2.27
Adenosine diphosphate-induced platelet aggregation in suspensions of washed rabbit platelets. Br J Haematol (1970) 2.27
Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene. J Clin Invest (1984) 2.07
Response of platelets to tissue injury. Biochem Pharmacol (1968) 2.01
Resolution and organization of platelet-rich mural thrombi in carotid arteries of swine. Am J Pathol (1967) 1.91
Release of permeability factors from the blood platelet. Proc Soc Exp Biol Med (1966) 1.86
Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens). Proc Natl Acad Sci U S A (1987) 1.82
Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med (2001) 1.75
Factors responsible for ADP-induced release reaction of human platelets. Am J Physiol (1975) 1.70
Fibrinogen and ADP-induced platelet aggregation. Blood (1978) 1.70
The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett (1997) 1.70
Genetic screening for hemophilia A (classic hemophilia) with a polymorphic DNA probe. N Engl J Med (1985) 1.67
Deposition of formed elements of blood on the intima and signs of intimal injury in the aorta of rabbit, pig, and man. Lab Invest (1972) 1.63
Adenosine diphosphate-induced platelet aggregation and vascular injury in swine and rabbits. Am J Pathol (1970) 1.60
Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. Eur J Pharmacol (2001) 1.59
Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br J Haematol (1995) 1.55
Alteration of the response of platelets to surface stimuli by pyrazole compounds. J Exp Med (1967) 1.48
The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation. Blood (1998) 1.48
Prevalence and significance of anticardiolipin antibodies in Crohn's disease. Dig Dis Sci (1994) 1.47
Thromboembolism: a manifestation of the response of blood to injury. Circulation (1970) 1.45
Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane-active drugs. Lab Invest (1979) 1.44
Sensitivity and long-term prognostic value of cardiac troponin-I increase shortly after percutaneous transluminal coronary angioplasty. Clin Cardiol (1998) 1.43
Platelet-surface interactions: relationship to thrombosis and hemostasis. Fed Proc (1967) 1.42
Platelets, thrombosis and drugs. Drugs (1975) 1.40
Effect of ADP-induced shape change on incorporation of 32P into platelet phosphatidic acid and mono-, di- and triphosphatidyl inositol. Br J Haematol (1973) 1.38
Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187. J Lab Clin Med (1977) 1.35
Adenosine diphosphate-induced platelet aggregation and myocardial infarction in swine. Lab Invest (1967) 1.33
Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J Exp Med (1998) 1.31
Comparison of fibrinogen association with normal and thrombasthenic platelets on exposure to ADP or chymotrypsin. Blood (1979) 1.31
Platelet interaction with polymerizing fibrin. J Clin Invest (1972) 1.31
Changes in 32 p-labelling of platelet phospholipids in response to ADP. Br J Haematol (1972) 1.29
Release of 14C-serotonin during initial platelet changes induced by thrombin, collagen, or A23187. Blood (1977) 1.29
Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost (2005) 1.25
In vitro and in vivo functions of thrombin-treated platelets. Thromb Haemost (1976) 1.22
Thrombin generation and fibrin formation following injury to rabbit neointima. Studies of vessel wall reactivity and platelet survival. Lab Invest (1982) 1.22
Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors. Thromb Haemost (2000) 1.21
The effect of platelet age on platelet adherence to collagen. J Clin Invest (1968) 1.20
Changes in 32P-content of phosphatidic acid and the phosphoinositides of rabbit platelets during aggregation induced by collagen or thrombin. Br J Haematol (1974) 1.20
Cloning and expression of a cDNA coding for the anticoagulant hirudin from the bloodsucking leech, Hirudo medicinalis. Proc Natl Acad Sci U S A (1986) 1.20
Platelet economy (platelet survival and turnover). Br J Haematol (1966) 1.20
Rôle of platelets in thrombosis. Thromb Diath Haemorrh Suppl (1966) 1.19
Platelet aggregation and release: effects of low concentrations of thrombin or collagen. Am J Physiol (1973) 1.18
HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. J Clin Invest (1999) 1.18
Modification of platelet function. Ann N Y Acad Sci (1972) 1.18
Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist. Circulation (2001) 1.17
The effect of plasma proteins on the interaction of platelets with glass surfaces. J Lab Clin Med (1969) 1.16
Clq inhibition of the interaction of collagen with human platelets. J Immunol (1976) 1.16
Localized protein accumulation in the wall of the aorta. Exp Mol Pathol (1967) 1.15
The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin--a phosphoinositide 3-kinase-dependent mechanism. FEBS Lett (2001) 1.15
The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel. Br J Haematol (1998) 1.15
Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell lines. Thromb Haemost (1997) 1.14
The platelet cytoskeleton stabilizes the interaction between alphaIIbbeta3 and its ligand and induces selective movements of ligand-occupied integrin. J Biol Chem (1996) 1.13
Arterial thrombosis and protein S deficiency. Thromb Haemost (1989) 1.13
The human platelet ADP receptor activates Gi2 proteins. Biochem J (1995) 1.12
Effects on platelet function of removal of platelet sialic acid by neuraminidase. Lab Invest (1975) 1.12
ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Galphaq. Blood (2000) 1.12
Influence of apyrase on stability of suspensions of washed rabbit platelets. Proc Soc Exp Biol Med (1971) 1.12
Experimental hemostasis in normal dogs and dogs with congenital disorders of blood coagulation. Blood (1967) 1.11
Activation of ADP receptors and platelet function. Thromb Haemost (1997) 1.09
Characterization of CD1e, a third type of CD1 molecule expressed in dendritic cells. J Biol Chem (2000) 1.09
The role of blood and platelets in atherosclerosis and the complications of atherosclerosis. Thromb Diath Haemorrh (1975) 1.09
Thrombin regulates tissue factor and thrombomodulin mRNA levels and activities in human saphenous vein endothelial cells by distinct mechanisms. J Biol Chem (1993) 1.08
Effects of penicillin G on platelet aggregation, release, and adherence to collagen. Proc Soc Exp Biol Med (1973) 1.07